We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Xyrem Settlement Gets Green Light

Law360 (July 13, 2007, 12:00 AM EDT) -- A federal judge on Friday approved Jazz Pharmaceuticals Inc.'s $20 million settlement with the federal government over an investigation into the promotion of Xyrem, a narcolepsy treatment containing oft-abused GHB, by...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.